Sirona Biochem Corp(SRBCF)
USD --+0.00%
Reward29Low
Risk70High
📊75%Data
Revenue down 63% YoY
SRBCF
+0.0 · +0.00%
USD · PINK
Sirona Biochem Corp | Healthcare
Earnings Deterioration
Market Cap:1.63M
ℹ️
Reward Rating
29
Low
Bottom 1% (model universe)
75% data coverage
ℹ️
Risk Rating
70
High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on SRBCF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Sirona Biochem Corp?

, a cosmetic ingredient and drug discovery company, engages in the development and sale of cosmetic and pharmaceutical active ingredients in Canada and France.

SRBCF · Verdict

Limited reward · elevated risk

SRBCF's standout is volatility; balance sheet and cash flow weigh on the picture.

Based on 88% data coverage

SRBCF · Verdict

What’s working & what to watch

Strengths 1

  • Volatility95/100

    Top decile vs peers

Watchouts 4

  • Balance sheet6/100

    Current ratio 0.55

  • Cash flow6/100

    -5053% free-cash-flow margin

  • Profitability9/100

    -7312% net margin · -9810% ROE

  • Growth15/100

    Rev -31.0% CAGR · earnings -14.9%

Model-based scoring. For information only — not financial advice.

What is Sirona Biochem Corp?

, a cosmetic ingredient and drug discovery company, engages in the development and sale of cosmetic and pharmaceutical active ingredients in Canada and France. The company's programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, anti-wrinkle compound, and anti-viral program. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 1.63M.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue growth is subdued, limiting near-term earnings expansion.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Moderate volatility with meaningful macro and earnings sensitivity.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Low (29)

The scoring profile indicates weak reward characteristics across most factors, including valuation and momentum. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap1.63M
P/E RatioN/A
Dividend YieldN/A
52 Week High0.0534
52 Week Low0.0001
Last AnnualOctober
IPO DateN/A
IncorporatedUSA
Shares Outstanding259M
No. of EmployeesN/A
IndustryBiotechnology
ExchangePINK
Beta0.143
CurrencyUSD · Reports in CAD